Navigation Links
Federal Vaccine Court Rulings Against Autism Families Due to Government's Refusal to Fund Sound Science
Date:2/12/2009

"One more reason to distrust the government's vaccine program," says SafeMinds.

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- Autism advocacy organization SafeMinds regrets today's court ruling against three families who argued that vaccination contributed to their child's autism. The denial of compensation was based on inadequate vaccine safety science available to the court. The Department of Health and Human Services (HHS) is the defendant in "vaccine court" and is also responsible for carrying out the very vaccine safety research that is used for the court's decisions. This conflict of interest means the deck is stacked against families and is one more reason to doubt the integrity of the National Immunization Program.

"The government has its thumb on the scales of justice," said Jim Moody, director of SafeMinds and an advisor to the Petitioners Steering Committee of the U.S Federal Court of Claims. "The Vaccine Injury Compensation Act passed in 1986 gave immunity to vaccine manufacturers and removed the incentive to create safer products. Meanwhile, the law only gives the illusion that parents will have their day in court. The process is dysfunctional."

Two HHS agencies, the Centers for Disease Control (CDC) and the National Institutes of Health (NIH), are responsible for vaccine safety research. Even leading vaccine proponents have accused the CDC of carrying out safety research "on the cheap," and two systematic reviews by the Cochrane Collaboration have found vaccines studies to be of "poor quality" and "inadequate." The NIH director in charge of autism, Dr. Tom Insel, admitted that HHS's court cases prevent NIH from conducting autism-vaccine science. Last month, the government-dominated autism advisory committee blocked vaccine-autism studies from moving forward despite requests by their own scientific advisors and autism advocates. HHS gives billions of dollars to pharmaceutical companies to produce for-profit vaccines, and the CDC spends billions of dollars to expand the immunization of Americans, yet the CDC spends only $20 million on safety studies. Even this modest research is off-limits to the families' lawyers while the government's lawyers are allowed access.

"A neutral agency must initiate an extensive safety program, including studies of the health outcomes in vaccinated and unvaccinated groups," stated Sallie Bernard, executive director of SafeMinds. "Otherwise, trust in immunization will continue to deteriorate."

Over 5,000 petitions have been filed alleging vaccine damage to the developing brain and other immune and metabolic pathways giving rise to an autism diagnosis. The court has awarded approximately $5 million in compensation for such cases. Most cases are quietly settled, leaving the public in the dark. While the government has linked vaccine injury to autism, today's ruling demonstrates the legal process is arbitrary. Only sound science can say which and how many children with autism have a vaccine injury.

SafeMinds recognizes the bravery of the three families who now face a lifetime of inadequate support for their disabled children.


'/>"/>
SOURCE SafeMinds
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Federal Court Declares Vaccines Do Not Cause Autism
2. Pennsylvania Insurance Commissioner Praises Federal Reauthorization of Childrens Health Care
3. Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
4. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
5. U.S. Senate Acts to Protect Kids, Save Lives by Increasing Federal Tobacco Taxes
6. University of Minnesotas Internationally Recognized Stem Cell Experts Available for Interviews on What Lifting the Federal Funding Restrictions Will Mean to Stem Cell Research and to Patients Who Stand to Benefit
7. UTSA receives federal funding for fossil fuel research
8. ISSA: First Fitness Organization to Earn National Accreditation by a Federally Recognized Accrediting Agency
9. VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal
10. Federal Members of Advisory Committee Block Vaccine-Autism Research, Defy Wishes of Its Own Scientists, Autism Community, and Congress
11. Eli Lilly Pays a Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Zyprexa Off-Label Marketing Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Aliso Viejo, California (PRWEB) , ... June 27, 2016 , ... ... that are fully customizable inside of Final Cut Pro X," said Christina Austin - ... with another unique style. Final Cut Pro X users can now reveal ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: